Cargando…

Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression

Background: The molecular regulation of increased MGMT expression in human brain tumors, the associated regulatory elements, and linkages of these to its epigenetic silencing are not understood. Because the heightened expression or non-expression of MGMT plays a pivotal role in glioma therapeutics,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibrahim Al-Obaide, Mohammed A., Arutla, Viswanath, Bacolod, Manny D., Wang, Wei, Zhang, Ruiwen, Srivenugopal, Kalkunte S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958331/ https://www.ncbi.nlm.nih.gov/pubmed/33801310 http://dx.doi.org/10.3390/ijms22052492

Ejemplares similares

Transcriptional Pausing and Activation at Exons-1 and -2, Respectively, Mediate the MGMT Gene Expression in Human Glioblastoma Cells
por: Al-Obaide, Mohammed A. Ibrahim, et al.
Publicado: (2021)

Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging
por: Punganuru, Surendra Reddy, et al.
Publicado: (2019)

Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies
por: Madala, Hanumantha Rao, et al.
Publicado: (2018)

Cancer-Specific Biomarker hNQO1-Activatable Fluorescent Probe for Imaging Cancer Cells In Vitro and In Vivo
por: Punganuru, Surendra Reddy, et al.
Publicado: (2018)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action
por: Punganuru, Surendra R., et al.
Publicado: (2020)

S-phase Specific Downregulation of Human O(6)-Methylguanine DNA Methyltransferase (MGMT) and its Serendipitous Interactions with PCNA and p21(cip1) Proteins in Glioma Cells
por: Mostofa, AGM, et al.
Publicado: (2018)

The Process and Regulatory Components of Inflammation in Brain Oncogenesis
por: Mostofa, A.G.M., et al.
Publicado: (2017)

Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models
por: Punganuru, Surendra R., et al.
Publicado: (2018)

Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts
por: Madala, Hanumantha Rao, et al.
Publicado: (2017)

New insights into estrogenic regulation of O(6)-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O(6)-benzylguanine indicates fresh avenues for therapy
por: Paranjpe, Ameya, et al.
Publicado: (2016)

Putative bovine topological association domains and CTCF binding motifs can reduce the search space for causative regulatory variants of complex traits
por: Wang, Min, et al.
Publicado: (2018)

A Unified Transcriptional, Pharmacogenomic, and Gene Dependency Approach to Decipher the Biology, Diagnostic Markers, and Therapeutic Targets Associated with Prostate Cancer Metastasis
por: Bacolod, Manny D., et al.
Publicado: (2021)

MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances response to temozolomide
por: Bobustuc, George C., et al.
Publicado: (2018)

The murine IgH locus contains a distinct DNA sequence motif for the chromatin regulatory factor CTCF
por: Ciccone, David N., et al.
Publicado: (2019)

On the Value of Intra-Motif Dependencies of Human Insulator Protein CTCF
por: Eggeling, Ralf, et al.
Publicado: (2014)

Do we really know who has an MGMT methylated glioma? Results of an international survey regarding use of MGMT analyses for glioma
por: Malmström, Annika, et al.
Publicado: (2020)

Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
por: Gong, Mingjie, et al.
Publicado: (2017)

MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
por: Oldrini, Barbara, et al.
Publicado: (2020)

The Significance of MGMT Promoter Methylation Status in Diffuse Glioma
por: Jovanović, Nikola, et al.
Publicado: (2022)

CTCF maintains regulatory homeostasis of cancer pathways
por: Aitken, Sarah J., et al.
Publicado: (2018)

Identification and analysis of consensus RNA motifs binding to the genome regulator CTCF
por: Kuang, Shuzhen, et al.
Publicado: (2020)

CGGBP1-regulated cytosine methylation at CTCF-binding motifs resists stochasticity
por: Patel, Manthan, et al.
Publicado: (2020)

CTCF Expression and Dynamic Motif Accessibility Modulates Epithelial–Mesenchymal Gene Expression
por: Johnson, Kelsey S., et al.
Publicado: (2022)

MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
por: ABE, Hideaki, et al.
Publicado: (2018)

Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas
por: Gömöri, Éva, et al.
Publicado: (2012)

Relationship between MGMT gene expression and treatment effectiveness and prognosis in glioma
por: Li, Qiang, et al.
Publicado: (2017)

Immunohistochemical expression of MGMT in gliomas and its role in ascertaining patient survival
por: Butta, Shristi, et al.
Publicado: (2021)

Diagnostic Accuracy of Immunohistochemistry in Detecting MGMT Methylation Status in Patients with Glioma
por: Sahara, Nita, et al.
Publicado: (2021)

MGMT promoter methylation in 1p19q-intact gliomas
por: Kinslow, Connor, et al.
Publicado: (2023)

O(6)-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation
por: Kreth, Simone, et al.
Publicado: (2011)

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
por: Håvik, Annette Bentsen, et al.
Publicado: (2012)

Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells
por: Ryu, Chung Heon, et al.
Publicado: (2012)

miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
por: Quintavalle, Cristina, et al.
Publicado: (2013)

Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
por: Qiu, Zhi-Kun, et al.
Publicado: (2014)

Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma
por: Zhang, Yang, et al.
Publicado: (2019)

An intronic genetic variation of MGMT affects enhancer activity and is associated with glioma susceptibility
por: Huang, Liming, et al.
Publicado: (2018)

Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II
por: Karschnia, Philipp, et al.
Publicado: (2020)

Predicting MGMT Promoter Methylation in Diffuse Gliomas Using Deep Learning with Radiomics
por: Chen, Sixuan, et al.
Publicado: (2022)

The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
por: Xu, Haoyue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cl938rhrbr35am2ldgut3b04pp